Literature DB >> 8081670

A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study.

M C Creemers1, M A Van 't Hof, M J Franssen, L B Van de Putte, F W Gribnau, P L Van Riel.   

Abstract

A Dutch Functional Index (DFI) for AS has been developed, containing 37 questions in essence this is a modification of a French index with additional questions. Internal consistency, reproducibility, criterion and construct validity and sensitivity to change were studied in different groups of AS patients. In a group of 149 patients the questionnaire was completed and internal consistency calculated (Cronbach's alpha = 0.94) after exclusion of three items. Reproducibility was studied in 39 patients with stable disease; Pearson correlation was 0.94. Criterion validity, against a 'gold standard' i.e. experts' observation of 25 items, was studied in 19 patients; r = 0.85. In a 48-week NSAID study patients were enrolled after a washout period: DFI scores before and after treatment showed significant improvement (P < 0.02). There were 187 DFI with corresponding clinical measurements, correlations varied from -0.30 to 0.68. Estimated measurement-remeasurement correlation was 0.87. The DFI is, thus, a potentially useful instrument, which is valid, reliable and sensitive to the effects of NSAID treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8081670     DOI: 10.1093/rheumatology/33.9.842

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity.

Authors:  W P Maksymowych; N Adlam; D Lind; A S Russell
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

3.  Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis.

Authors:  A van Tubergen; R Landewé; L Heuft-Dorenbosch; A Spoorenberg; D van der Heijde; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.